The development of transcatheter aortic valve replacement (TAVR) has transformed the
treatment of patients with aortic valve disease. This procedure now is used widely for …

Transcatheter aortic valve replacement (TAVR) is rapidly gaining popularity as a viable
option in the management of patients with symptomatic aortic stenosis (AS) and high risk for …

Anesthesia for transcatheter aortic valve implantation: an u... : Current Opinion in
Anesthesiology Anesthesia for transcatheter aortic valve implantation: an update : Current …

An increasing number of patients with a high risk for surgery because of advanced age and
associated comorbidities that significantly increase the perioperative risk successfully …

Journal of Cardiothoracic and Vascular Anesthesia 31 (2017) 777–790 a prominent role in
the conduct of the procedure in both Europe and the United States. 1–3 The adoption of …

AORTIC VALVE REPLACEMENT (AVR) continues to be the standard for treatment of aortic
stenosis. The overall operative mortality for patients undergoing a surgical AVR (SAVR) …

The first human percutaneous transcatheter aortic valve replacement (TAVR) procedure was
performed by Dr Alain Cribier in Rouen, France in 2002. 1 This innovative technology used …

Transcatheter aortic valve replacement (TAVR) is performed with increasing frequency in the
United States since Food and Drug Administration approval in 2011. The procedure involves …

Preprocedural, multidisciplinary assessment of the patient is essential prior to TAVI and
should include a full anesthetic evaluation, consideration of patient comorbidities, and …

Transcatheter aortic valve implantation (TAVI) has become the mainstay for high-risk or
inoperable patients with symptomatic aortic valve stenosis, and research regarding the use …